Reason to trust
How Our News is Made
Strict editorial policy that focuses on accuracy, relevance, and impartiality
Ad discliamer
Morbi pretium leo et nisl aliquam mollis. Quisque arcu lorem, ultricies quis pellentesque nec, ullamcorper eu odio.
Bitcoin (BTC) has reclaimed a position above $44,000 a day after the US Federal Reserve declared a rate pause in its latest meeting. At the same time, a surge in volatility resulted in the liquidation of over $63 million in leveraged positions, according to data from Coinglass. Amidst this volatility, two noteworthy crypto projects, Injective (INJ) and InQubeta (QUBE), steal the spotlight, showcasing their resilience in the market.
InQubeta is dedicated to bridging the divide between AI startups and investors. With its deflationary model and comprehensive suite of services, QUBE makes itself a compelling crypto to buy, poised to enhance any portfolio. Meanwhile, the price trajectory of the Injective in 2023 paints a remarkable picture, experiencing a parabolic uptrend and boasting an impressive year-to-date surge of nearly 2,700%.
Let’s explore InQubeta and Injective as they steal the spotlight amidst the Bitcoin volatility that cost traders over $63 million.
InQubeta (QUBE): Redefining Investments in Crypto AI Sector with Its NFT Marketplace.
InQubeta, a new DeFi crypto, has seized the spotlight. It is introducing a groundbreaking concept as the first crypto crowdfunding platform enabling fractional investment in AI startups using QUBE tokens. Built on the Ethereum blockchain, QUBE utilizes the advantages of this robust technology to establish a secure and seamless investment ecosystem for both AI startups and investors.
As a deflationary ERC20 token, QUBE presents a distinctive investment opportunity. Its approach features a 2% buy and sell tax allocated to a burning wallet and a 5% sell tax directed to a dedicated reward pool. Investors holding QUBE can earn rewards by staking their tokens. This makes it an enticing prospect for those seeking the best crypto to buy to diversify crypto portfolios and recognize the growth potential of AI technology startups.
InQubeta’s innovation extends further by transforming each investment opportunity into an NFT and fractionalizing it. This strategy offers a flexible investment approach for individuals with varying budgets. The trending NFT marketplace funds AI startups through reward and equity-based NFTs. This establishes a symbiotic relationship wherein QUBE token holders can seamlessly invest in projects they believe in.
This new DeFi crypto token is also designed as a governance token, empowering holders to actively engage in decision-making processes concerning the platform’s development, operation, and future trajectory. As more investors and startups engage with the InQubeta platform, the anticipated increase in demand for QUBE is poised to elevate the token’s value over time. Investors holding and staking QUBE tokens stand to benefit from potential price appreciation and earn rewards from the dedicated reward pool.
Bitcoin (BTC): Exploring the Surge in Volatility and Trader Setbacks.
The growing momentum of the ongoing Bitcoin rise has strengthened, with Bitcoin’s yearly volatility climbing from a several-week low of 40% at the start of December. Data from Coinglass shows that a spike in BTC’s unpredictability caused traders to experience losses surpassing $63 million.
Many positions had to be quickly liquidated, resulting in $38.4 million in losses. Also, $24.7 million in holdings were liquidated when Bitcoin price briefly dropped below $43,000. The high fluctuations led to selling numerous risky positions, reaching a several week peak for this measure. This brought BTC’s yearly volatility to 51.97%.
Injective (INJ): Prices Skyrocket to New High With Strong Buying Signal.
Injective has taken the spotlight with its recent uptrend in price. This uptick peaked when INJ achieved a new all-time high of $34.64 on December 15, experiencing a minor retracement afterwards. Despite indications of short-term weakness, the general sentiment leans bullish, anticipating further price appreciation.
Analysts suggest that Injective swift price ascent seems disconnected from fundamental spot market dynamics, attributing it predominantly to leverage utilized by derivatives traders aiming to capitalize on market volatility. Given the optimistic multi-timeframe outlook, traders might consider accumulating INJ during price dips.
Conclusion
With Bitcoin volatility costing traders over $63 million, InQubeta and Injective capture the spotlight with their bullish signals for buying. InQubeta leads the way with its trending NFT marketplace and deflationary model, transforming the crypto AI market. The presale is a fantastic opportunity to be part of the AI revolution. Investors can purchase the token via the website using tokens like ETH, BTC, or USDT.
